Allegheny Health Network (Pittsburg PA)

Pittsburgh, Pennsylvania 15212

0 studies enrolling now · 2 studies all time

What they study most

COVID-19 Pneumonia, Non-Hodgkin's Lymphoma

Studies at this site

• A Dose Escalation Study of Glofitamab (RO7082859) as a Single Agent and in Combination With Obinutuzumab, Administered After a Fixed, Single Pre-treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-cell Non-hodgkin's Lymphoma — Running, not enrolling
• A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia — Completed